Couple Wins Over $2.5M In Calif.'s Virtual Asbestos Trial
Couple Wins Over $2.5M In Calif.'s Virtual Asbestos Trial
Introduction
Last week, the California Superior Court for Alameda County jury awarded a retired Navy admiral and his wife over $2.5 million in the conclusion of a virtual asbestos trial against Metalclad Insulation LLC.
The September 28th verdict was the result of hearing arguments for two-and-a-half months and more than a week of deliberations. A 12-member jury held the lone remaining defendant Metalclad just seven percent liable for negligently failing to recall or warn about the risks associated with the asbestos-laden insulation, which the company supplied to Navy yards for years.
The lawsuit was filed by 82-year-old retired Rear Adm. Ronald Wilgenbusch, and his wife, Judith, claiming that the asbestos exposure during the installation and removal of Metalclad-supplied insulation on several Navy ships in the U.S. Navy caused his mesothelioma. Wilgenbusch will roughly receive $1.8 million, and his wife will receive $750,000 in economic and non-economic damages.
The jury cleared Metalclad of the punitive damages claim and held the Navy 51% liable. Wilgenbusch also bored 4% of the liability, and the other ten companies were held accountable for the rest.
The case, originally headed for an in-person trial in July, was moved for an online trial via Zoom by Alameda County Superior Court Judge Brad Seligman, after finding that one juror came down with a fever.
It is the second of the three that went for trial via Zoom in Alameda County. The first one ended in a defense verdict for Honeywell over a $70 million asbestos suit. The third one kicked off a couple of weeks ago with an argument by a former Navy sailor's counsel that the plaintiff was exposed to cancer-causing asbestos, installed on a Navy aircraft carrier, which was supplied by Metalclad.
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…